Showing 11-15 of 146 researchers:
OM1 Launches HS Dataset to Expand Use of Real-World Evidence in Dermatology

Practical Dermatology September 22, 2023 Read the full article >> OM1 is expanding its Dermatology Network to include almost 26,000 hidradenitis suppurativa (HS) patient records. “HS patients benefit when all available information on their journey can be surfaced and used to improve care and decision-making,” Joseph Zabinski tells DermWire. He is the Managing Director of AI and  Personalized Medicine at OM1. “Much of this[…]

OM1 Launches Hidradenitis Suppurativa Dataset to Expand Real-World Evidence in Dermatology

Business Wire September 21, 2023 Read the full release >> BOSTON–(BUSINESS WIRE)–OM1 a leading real-world data, AI and technology company with a focus on chronic diseases, today announced the continued expansion of its Dermatology Network to include Hidradenitis Suppurativa (HS), a systemic inflammatory disease, enhancing the dataset with almost 26,000 patient records. Studies continue to show the link between[…]

The 2023 PharmaVoice 100 Awards Dr. Carl Marci

PharmaVoice Sept. 19. 2023 Read the full article >> The mental health crisis in the U.S. has reached a fever pitch with an estimated one in five adults experiencing some form of mental illness, according to the NIH. For Dr. Carl Marci, the dire need for new mental health solutions has propelled him throughout his 30-year[…]

Reclaiming registries for integrated evidence generation throughout the product life cycle

BioPharma Dive 9/18/23 Read the full article >> Integrated Evidence Generation Integrated evidence generation (IEG) is a framework for generating evidence to support decision-making in healthcare. IEG leverages an ensemble of existing real-world data sources and new data collection to generate evidence that is ‘fit-for-purpose’[i], meaning that the real-world data (RWD) and the evidence that[…]

What Piece of Conventional Industry Wisdom Do You Think is Misguided, Outdated, or Just Plain Wrong?

Pharma’s Almanac 9/15/23 Read the full article >> Sonja Wustrack, Managing Director of Integrated Evidence Generation, OM1 There are two points to this question around RWD and RWE today. The first piece is the misconception that we primarily need larger volumes of higher quality RWD and better data standards to shift the paradigm for clinical research to incorporate RWE[…]